Research Suggests Reversing Stem Cell Aging in Sickle Cell Disease is Possible

Researchers at St. Jude Children's Research Hospital have discovered that prematurely aged blood stem cells in individuals with sickle cell disease could potentially be treated using anti-aging medications. A study published in Science Translational Medicine indicates that senolytics improved disease symptoms in model systems, offering new avenues for therapeutic interventions, including gene therapies.